Results 231 to 240 of about 198,741 (309)

Immunosuppression and Surgery‐Free Interval in Granulomatosis With Polyangiitis Airway Stenosis

open access: yesThe Laryngoscope, Volume 136, Issue 4, Page 1858-1865, April 2026.
Subglottic and tracheal stenosis are severe manifestations of granulomatosis with polyangiitis (GPA) that often require both endoscopic intervention and systemic immunosuppression. Rituximab may help stabilize GPA‐related airway disease by prolonging the interval between endoscopic procedures and delaying relapse.
Sydney J. Torres   +6 more
wiley   +1 more source

Should Histology Guide Treatment Decisions in IgA Nephropathy?

open access: yesKidney International Reports
Haresh Selvaskandan, Harish Seethapathy
doaj   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

open access: yesMedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source

LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients

open access: yesLupus Science and Medicine
Obbo W Bredewold   +6 more
doaj   +1 more source

Cryptococcid Sweet Syndrome in the Setting of Hydralazine‐Induced ANCA Vasculitis: A Case Report

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 4, Page 356-361, April 2026.
ABSTRACT Acute febrile neutrophilic dermatosis, also known as Sweet syndrome, is an inflammatory skin condition characterized by the rapid onset of painful, erythematous plaques or nodules with neutrophilic infiltrate on histology. Rarely, acellular bodies surrounded by vacuolated spaces have been noted within the neutrophilic infiltrate, mimicking ...
Jenna Vroman   +4 more
wiley   +1 more source

Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus

open access: yesInternational Journal of Dermatology, Volume 65, Issue 4, Page 783-789, April 2026.
ABSTRACT Background The aim was to assess the long‐term effect of belimumab on the cutaneous manifestations of patients with systemic lupus erythematosus (SLE). Methods The retrospective analysis included 29 patients with SLE. Cutaneous disease activity was assessed using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and the
Diana Schellin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy